Published on 4 May 2024 on Zacks via Yahoo Finance
Agios (AGIO) Q1 Earnings Surpass, Sales Miss Estimates
Agios Pharmaceuticals AGIO reported a loss of $1.45 per share in first-quarter 2024, narrower than the Zacks Consensus Estimate of a loss of $1.64. In the year-ago quarter, the company reported a loss of $1.47.
AGIO reported revenues of $8.2 million, which slightly missed the Zacks Consensus Estimate of $8.4 million. In the year-ago quarter, the company recorded revenues of $5.6 million.
Quarter in Detail